Notify me when Pegasus Partners Ltd. files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q3 2024 | 171 | $1,067,794,541 | +$38,920,600 | -$21,419,250 | +$17,501,350 | ITOT, IVV, IWY, IWV, IWX | 13F-HR | 01 Nov 2024, 12:37 |
| Q2 2024 | 166 | $991,538,794 | +$61,568,456 | -$32,329,810 | +$29,238,646 | ITOT, IVV, IWY, IWV, IWR | 13F-HR | 07 Aug 2024, 17:43 |
| Q1 2024 | 150 | $943,560,993 | +$45,482,230 | -$19,031,099 | +$26,451,131 | ITOT, IVV, IWV, IWY, IWR | 13F-HR | 24 Apr 2024, 15:50 |
| Q4 2023 | 143 | $856,242,331 | +$101,369,377 | -$36,477,762 | +$64,891,615 | ITOT, IVV, IWV, IWR, IWY | 13F-HR | 12 Feb 2024, 14:55 |
| Q3 2023 | 133 | $710,972,720 | +$87,614,221 | -$21,234,252 | +$66,379,969 | ITOT, IVV, IWV, IWR, VONV | 13F-HR | 13 Nov 2023, 15:30 |
| Q2 2023 | 124 | $680,160,597 | +$20,393,536 | -$18,743,429 | +$1,650,107 | ITOT, IVV, IWR, IWV, VONV | 13F-HR | 04 Aug 2023, 12:52 |
| Q1 2023 | 120 | $631,798,892 | +$19,624,407 | -$33,243,254 | -$13,618,847 | ITOT, IVV, IWR, IWV, VONV | 13F-HR | 10 May 2023, 10:24 |
| Q4 2022 | 120 | $607,812,743 | +$98,078,176 | -$15,494,534 | +$82,583,642 | ITOT, IVV, IWV, IWR, VONV | 13F-HR | 09 Feb 2023, 11:35 |
| Q3 2022 | 121 | $487,900,000 | +$58,682,095 | -$19,596,629 | +$39,085,466 | IVV, ITOT, IWV, IWR, VONV | 13F-HR | 10 Nov 2022, 12:44 |
| Q2 2022 | 125 | $480,447,000 | +$47,470,761 | -$48,355,755 | -$884,994 | IVV, ITOT, IWV, VONV, IWR | 13F-HR | 12 Aug 2022, 16:04 |
| Q1 2022 | 136 | $571,542,000 | +$48,694,618 | -$18,204,503 | +$30,490,115 | IVV, ITOT, VONV, IWV, IWR | 13F-HR | 13 May 2022, 15:10 |
| Q4 2021 | 142 | $571,440,000 | +$41,265,893 | -$72,676,335 | -$31,410,442 | IVV, ITOT, VONV, IWV, IWR | 13F-HR | 09 Feb 2022, 13:22 |
| Q3 2021 | 161 | $551,221,000 | +$57,955,864 | -$17,978,773 | +$39,977,091 | IVV, VONV, IWV, ITOT, IJH | 13F-HR | 12 Nov 2021, 14:15 |
| Q2 2021 | 162 | $513,484,000 | +$77,190,286 | -$34,570,218 | +$42,620,068 | IVV, IWV, VONV, IWR, IJH | 13F-HR | 13 Aug 2021, 09:47 |
| Q1 2021 | 162 | $456,429,000 | +$93,041,240 | -$52,678,403 | +$40,362,837 | IVV, IWV, VONV, IJH, SPY | 13F-HR | 14 May 2021, 09:44 |
| Q4 2020 | 147 | $394,438,000 | +$28,468,900 | -$7,826,972 | +$20,641,928 | IVV, SPY, IJH, IWV, AAPL | 13F-HR | 12 Feb 2021, 14:22 |
| Q3 2020 | 135 | $329,772,000 | +$21,229,718 | -$12,433,587 | +$8,796,131 | IVV, SPY, AAPL, IJH, IWV | 13F-HR | 13 Nov 2020, 15:49 |
| Q2 2020 | 137 | $308,226,000 | +$27,409,509 | -$26,632,845 | +$776,664 | IVV, SPY, IJH, AAPL, IWV | 13F-HR | 12 Aug 2020, 16:42 |
| Q1 2020 | 125 | $255,115,000 | +$53,639,589 | -$52,656,754 | +$982,835 | IVV, SPY, IJH, IWR, IWV | 13F-HR | 11 May 2020, 13:55 |
| Q4 2019 | 167 | $327,770,000 | +$41,469,720 | -$29,770,014 | +$11,699,706 | IVV, IJR, IWR, AAPL, IJH | 13F-HR | 11 Feb 2020, 19:32 |
| Q3 2019 | 179 | $292,738,000 | +$55,575,194 | -$98,011,425 | -$42,436,231 | IVV, IJR, IWR, IJH, MSFT | 13F-HR | 24 Oct 2019, 13:02 |
| Q2 2019 | 170 | $331,367,000 | +$51,185,648 | -$69,807,201 | -$18,621,553 | IVV, IJR, IWR, IJH, AAPL | 13F-HR | 30 Jul 2019, 13:41 |
| Q1 2019 | 136 | $343,128,000 | +$47,750,945 | -$84,526,278 | -$36,775,333 | IJR, IVV, IWR, IJH, AAPL | 13F-HR | 13 May 2019, 10:06 |
| Q4 2018 | 135 | $337,912,000 | +$76,247,812 | -$106,160,372 | -$29,912,560 | IVV, IWR, IJR, MDY, IJH | 13F-HR | 01 Feb 2019, 17:24 |
| Q3 2018 | 137 | $453,724,000 | +$38,733,526 | -$37,286,664 | +$1,446,862 | IJR, IVV, IJH, IWR, AAPL | Restatement | 07 Nov 2018, 11:48 |
| Q2 2018 | 144 | $433,614,000 | +$31,571,961 | -$73,503,355 | -$41,931,394 | IJR, IVV, IJH, IWR, AAPL | 13F-HR | 27 Jul 2018, 12:01 |
| Q1 2018 | 142 | $459,815,000 | +$59,032,138 | -$82,538,861 | -$23,506,723 | IJH, IVV, IJR, IWR, AAPL | 13F-HR | 09 May 2018, 10:43 |
| Q4 2017 | 156 | $487,579,000 | +$88,941,235 | -$62,876,093 | +$26,065,142 | IJH, IVV, IJR, IWR, AAPL | 13F-HR | 07 Feb 2018, 17:46 |
| Q3 2017 | 153 | $437,654,000 | +$87,990,705 | -$36,570,348 | +$51,420,357 | IJR, IVV, IJH, IWR, AAPL | 13F-HR | 09 Nov 2017, 12:06 |
| Q2 2017 | 149 | $376,451,000 | +$141,083,030 | -$11,596,768 | +$129,486,262 | IJR, IVV, IJH, IWR, AAPL | 13F-HR | 03 Aug 2017, 18:11 |
| Q1 2017 | 113 | $242,800,000 | +$38,902,077 | -$21,685,324 | +$17,216,753 | IJR, IVV, IWR, IJH, AAPL | 13F-HR | 27 Apr 2017, 12:52 |
| Q4 2016 | 112 | $226,961,000 | +$37,234,706 | -$29,711,722 | +$7,522,984 | IVV, IJR, IWR, JPM, AAPL | Restatement | 27 Feb 2017, 10:41 |
| Q3 2016 | 112 | $211,017,000 | +$20,061,711 | -$8,948,855 | +$11,112,856 | IVV, IWR, IJR, GSK, AAPL | 13F-HR | 07 Nov 2016, 09:58 |
| Q2 2016 | 113 | $193,190,000 | +$15,523,820 | -$9,428,351 | +$6,095,469 | IVV, IWR, GSK, PFE, AAPL | 13F-HR | 09 Aug 2016, 12:43 |
| Q1 2016 | 110 | $184,421,000 | +$45,301,846 | -$63,644,773 | -$18,342,927 | IVV, IWR, GSK, PFE, AAPL | 13F-HR | 12 May 2016, 16:43 |
| Q4 2015 | 93 | $199,377,000 | +$61,934,516 | -$37,668,729 | +$24,265,787 | IVV, GE, GSK, IWR, PFE | 13F-HR | 08 Jan 2016, 12:58 |
| Q3 2015 | 89 | $175,986,000 | +$6,078,752 | -$37,796,777 | -$31,718,025 | NTG, KMI, GSK, GE, PFE | 13F-HR | 05 Oct 2015, 12:34 |
| Q2 2015 | 99 | $226,860,000 | $0 | $0 | $0 | KMI, NTG, AAPL, BSCF, GSK | 13F-HR | 11 Aug 2015, 16:31 |